159 related articles for article (PubMed ID: 21088114)
1. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control.
Postma DS; O'Byrne PM; Pedersen S
Chest; 2011 Feb; 139(2):311-318. PubMed ID: 21088114
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
3. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
[TBL] [Abstract][Full Text] [Related]
4. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma.
Knox A; Langan J; Martinot JB; Gruss C; Häfner D
Curr Med Res Opin; 2007 Oct; 23(10):2387-94. PubMed ID: 17714607
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life.
Price DB; Williams AE; Yoxall S
Respir Res; 2007 Jul; 8(1):46. PubMed ID: 17610727
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
10. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
Xu J; Nave R; Lahu G; Derom E; Derendorf H
J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
[TBL] [Abstract][Full Text] [Related]
12. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
14. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
; Peters SP; Anthonisen N; Castro M; Holbrook JT; Irvin CG; Smith LJ; Wise RA
N Engl J Med; 2007 May; 356(20):2027-39. PubMed ID: 17507702
[TBL] [Abstract][Full Text] [Related]
16. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R
Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
[TBL] [Abstract][Full Text] [Related]
17. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS
Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
[TBL] [Abstract][Full Text] [Related]
20. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]